Chiome Bioscience Inc.TSE 4583
株式会社カイオム・バイオサイエンス · Pharmaceutical · FY ends Dec
Share price at FY-end
—
FY ending Dec 2025
Avg. director pay
¥22.3M
Internal directors
Top 10 shareholders
| # | Shareholder | Shares | Stake | Value | Dividends |
|---|
| 1 |
渡邊 賢二
|
2,150,000 |
3.14% |
— |
— |
| 2 |
太田 邦史
|
962,700 |
1.40% |
— |
— |
| 3 |
江平 文茂
|
957,500 |
1.39% |
— |
— |
| 4 |
楽天証券株式会社共有口
|
933,800 |
1.36% |
— |
— |
| 5 |
平田 重一
|
737,200 |
1.07% |
— |
— |
| 6 |
日本証券金融株式会社
|
707,300 |
1.03% |
— |
— |
| 7 |
御所野 侃
|
687,000 |
1.00% |
— |
— |
| 8 |
飯作 哲男
|
607,000 |
0.88% |
— |
— |
| 9 |
巻幡 俊
|
569,500 |
0.83% |
— |
— |
| 10 |
山戸 福太郎
|
550,000 |
0.80% |
— |
— |
Officers' holdings and pay
| Name | Title | Shares | Value | Pay |
|---|
| 小池 正道 |
President & Representative Director |
120,700 |
— |
— |
| 美女平 在彦 |
Executive Vice President & Director |
130,800 |
— |
— |
| 田岡 照世 |
Director |
102,700 |
— |
— |
| 河合 弘行 |
Director |
— |
— |
— |
| 降矢 朗行 |
Director |
13,000 |
— |
— |
| 山川 善之 |
Director |
— |
— |
— |
| 坂本 二朗 |
Director |
— |
— |
— |
Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.
Per-share data by fiscal year
| Fiscal year | Price | EPS | P/E | Dividend | Shares issued |
|---|
| FY ending Dec 2025 |
— |
¥-14.47 |
— |
— |
68,453,800 |
| FY ending Dec 2024 |
— |
¥-17.54 |
— |
— |
66,969,000 |
| FY ending Dec 2023 |
— |
¥-24.62 |
— |
— |
52,640,200 |
| FY ending Dec 2022 |
— |
¥-28.26 |
— |
— |
48,423,500 |
| FY ending Dec 2021 |
— |
¥-36.74 |
— |
— |
40,781,500 |
| FY ending Dec 2020 |
— |
¥-36.06 |
— |
— |
39,505,200 |
| FY ending Dec 2019 |
— |
¥-44.61 |
— |
— |
33,283,500 |
Source: annual securities reports on EDINET. Values are estimates.
Methodology